Integrative Health Technologies, Inc. Stock Other OTC
Equities
IHTI
US45822A2078
Biotechnology & Medical Research
Financials (USD)
Sales 2008 | 0.43 | Sales 2009 | 0.45 | Capitalization | 1.22M |
---|---|---|---|---|---|
Net income 2008 | - | Net income 2009 | - | EV / Sales 2008 | 14,379,727 x |
Net Debt 2008 | 99.02K | Net Debt 2009 | 94.3K | EV / Sales 2009 | 2,939,517 x |
P/E ratio 2008 |
231
x | P/E ratio 2009 |
31.6
x | Employees | - |
Yield 2008 * |
-
| Yield 2009 |
-
| Free-Float | 48.33% |
Managers | Title | Age | Since |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
Samuel C. Keith
CIO | Chief Investment Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilbert R. Kaats
CEO | Chief Executive Officer | - | - |
1st Jan change | Capi. | |
---|---|---|
+3.13% | 43.43B | |
+48.83% | 41.69B | |
+8.49% | 41.31B | |
-10.82% | 27.14B | |
+8.26% | 25.28B | |
-23.69% | 18.47B | |
+1.58% | 12.33B | |
+32.83% | 12.59B | |
+6.63% | 11.03B |